U002 Addressing Unmet Needs in Diverse Populations: Therapeutic, Aesthetic, and Investigational Approaches
DESCRIPTION
Obstacles to achieving the safest and best outcomes in underserved patients include insufficient data, suboptimal assessment tools, and sociocultural considerations. This session will provide dermatologists in practice and in training with better understanding of these obstacles, prospective and proactive strategies to address them, and hence the ability to deliver more appropriate and effective care. Audience-interactive presentations and panel discussion include hidradenitis suppurativa, keloids, and lasers. Patient communication within healthcare systems and the legacy of clinical study designs will be discussed from evidence-based and experiential/case-based perspectives.
LEARNING OBJECTIVES
Identify and distinguish barriers to optimal treatment and compliance in dermatologic patients of diverse skin types, ethnicities and cultures.
Formulate strategies to address unmet needs for diverse patient populations in medical and procedural dermatology.
Develop evidence-based treatment plans that maximize safety and outcomes in diverse patient populations.
SCHEDULE
7:30 AM
Welcome & Introduction
Valerie D. Callender, MD, FAAD, Hema A Sundaram, MD, FAAD
7:35 AM
Overcoming Barriers in the Treatment of Keloids
Donald A. Glass II, MD, PhD, FAAD
7:50 AM
The Surgical Management of Hidradenitis Suppurativa
Zain U Syed, MD, FAAD
8:05 AM
Lasers in Patients with Darker Skin Types
Shilpi Khetarpal, MD, FAAD
8:20 AM
Questions & Answers
DIRECTOR
Valerie D. Callender, MD, FAAD
CO-DIRECTOR
Hema A Sundaram, MD, FAAD
SPEAKERS
Donald A. Glass II, MD, PhD, FAAD
Shilpi Khetarpal, MD, FAAD
Zain U Syed, MD, FAAD
HANDOUTS
DISCLOSURES
Valerie D. Callender, MD, FAAD
Aerolase – Advisory Board(Stock Options), Speaker/Faculty Education(Honoraria); Altree – Stockholder Private Company(Stock Options); Arcutis Biotherapeutics – Speaker(Honoraria); Beiersdorf, Inc. – Speaker(Honoraria); Callender Center for Clinical Research – Founder(No Compensation Received); Eli Lilly – Speaker/Faculty Education(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Elsevier Inc. – Independent Contractor(Honoraria); Incyte – Investigator(Grants/Research Funding); Janssen Biotech – Investigator(Grants/Research Funding); L'Oreal USA Inc. – Consultant(Honoraria), Investigator(Honoraria); La Roche-Posay - L'Oreal Group – Advisory Board(Honoraria); Ortho Dermatologics – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Prollenium Medical Technologies – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals Inc – Investigator(Grants/Research Funding); Restore Biologics – Advisory Board(Honoraria); Sinclair Pharma – Investigator(Grants/Research Funding); SkinCeuticals LLC – Advisory Board(Honoraria), Speaker(Honoraria); symatese – Investigator(Grants/Research Funding); TEOXANE Laboratories – Investigator(Grants/Research Funding); Unilever – Advisory Board(Honoraria); UpToDate – Other(Patent royalties or other compensation for Intellectual Property Rights); Veradermics – Advisory Board(Honoraria); VeraDermics Inc. – Investigator(Grants/Research Funding); WoltersKluwer Health – Independent Contractor(Patent royalties or other compensation for Intellectual Property Rights);
Donald A. Glass II, MD, PhD, FAAD
Atlas Ventures – Consultant (1099 relationship)(Honoraria); Exigent Therapeutics – Consultant (1099 relationship)(Honoraria);
Shilpi Khetarpal, MD, FAAD
Allergan Aesthetics – Advisory Board(Honoraria); Benev – Investigator(Grants/Research Funding); Crown Laboratories, Inc. – Consultant(Honoraria); Galderma Laboratories, LP – Speaker(Honoraria); Musculoskeletal Transplant Foundation – Consultant(Honoraria); Nutrafol – Consultant (1099 relationship)(Honoraria); Revive Advanced Training Consultants – Speaker/Faculty Education(Fees); Veradermics – Advisory Board(Honoraria);
Hema A Sundaram, MD, FAAD
Advanced Aesthetic Technologies – Consultant(Honoraria); Allergan, Inc – Consultant(Honoraria); Bioscience Gmbh – Investigator(Grants/Research Funding); Cellese – Consultant(Honoraria); Evolus, Inc. – Investigator(Grants/Research Funding); Fillmed – Consultant (1099 relationship)(Honoraria); Galderma USA – Investigator(Grants/Research Funding); IBSA – Consultant(Honoraria); JEUNE Inc. – Consultant(Honoraria); La Roche-Posay – Consultant (1099 relationship)(Honoraria); Menarini Group – Investigator(Grants/Research Funding); Prollenium Medical Technologies – Consultant(Honoraria); Quantificare – Investigator(Grants/Research Funding); Recros Medica – Investigator(Grants/Research Funding); Samyang Biopharmaceuticals – Investigator(Grants/Research Funding); SkinCeuticals LLC – Consultant(Honoraria); TEOXANE Laboratories – Investigator(Grants/Research Funding); Turn biotechnologies – Consultant(Honoraria);
Zain U Syed, MD, FAAD
Castle Biosciences, Inc – Advisory Board(Honoraria), Speaker(Honoraria);